Potomac Transactions advises on the sale of contactology laboratory LCS, a developer of innovative specialty lenses

LCS is a contact lens laboratory that develops specialty lenses, including patented hybrid lenses combining flexibility and rigidity to address complex pathologies of the eye. These lenses address visual needs not addressed by traditional and corrective lenses.  

LCS will continue to pursue its strategy of innovation and organic growth in France and abroad while carrying out possible targeted acquisitions across European markets. 

At the end of a process led by Potomac Transactions between May 2021 and April 2022, Go Capital exited the shareholding structure, returning control of the company to manager and shareholder Emmanuel Veillard,  with the entry of Sodero Gestion and CEN as minority shareholders.   

Go Capital is an investment fund specialized in innovation, that manages more than €250 million and supports socially responsible and ambitious projects. Following the takeover of Laboratoire LCS by Emmanuel Veillard more than 10 years ago, GO Capital believed in the company’s development potential and financed its cash flow needs to develop its product portfolio.